This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Vinderjit Sarjit Bhumra: Innovator in Pharmaceutical Excipients
Introduction
Vinderjit Sarjit Bhumra is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals through his innovative work in developing excipients for various dosage forms. His expertise and dedication to advancing pharmaceutical technology have earned him recognition in the industry.
Latest Patents
Vinderjit holds 1 patent for a groundbreaking invention titled "A solvent free process of obtaining an insoluble fiber rich fraction from seeds." This patent discloses a multifunctional fiber-rich fraction (FRF) and highly purified FRF that serve as excipients for pharmaceutical dosage forms. These excipients can be utilized as binders, disintegrants, fillers, dispersing agents, coating agents, film-forming agents, thickeners, and more. The FRF and highly purified FRF are also applicable in controlled release, targeted release, and other specialized delivery systems, as well as in food and cosmetics formulations.
Career Highlights
Vinderjit has demonstrated a strong commitment to innovation throughout his career. His work has focused on enhancing the effectiveness and versatility of pharmaceutical formulations. His contributions have paved the way for improved drug delivery systems that benefit both patients and healthcare providers.
Collaborations
Vinderjit has collaborated with esteemed colleagues, including Maharukh Tehmasp Rustomjee and Anilkumar Surendrakumar Gandhi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical sciences.
Conclusion
Vinderjit Sarjit Bhumra is a distinguished inventor whose work in developing multifunctional excipients has the potential to revolutionize pharmaceutical formulations. His innovative approach and dedication to research continue to make a significant impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile